Table 1 Distribution of RON and MET expression, and biological indicators
RON | MET | |||||
|---|---|---|---|---|---|---|
Clinical characteristics | Positive (%) | Negative (%) | P -value | Positive (%) | Negative (%) | P-value |
Histological grade | ||||||
 Grade I | 2 (1.1) | 20 (10.9) | 0.003 | 4 (2.2) | 18 (9.8) | <0.0001 |
 Grade II | 22 (12.0) | 58 (31.7) | 25 (13.7) | 55 (30.1) | ||
 Grade III | 36 (19.7) | 45 (24.6) | 83 (45.4) | 28 (15.3) | ||
Tumour shape | ||||||
 Papillary | 31 (16.9) | 95 (51.9) | 0.005 | 44 (24.0) | 82 (44.8) | <0.0001 |
 Nonpapillary | 29 (15.8) | 28 (15.3) | 38 (20.8) | 19 (10.4) | ||
Tumour size | ||||||
 ⩽1 cm | 5 (2.7) | 31 (16.9) | 0.003 | 8 (4.4) | 28 (15.3) | 0.0004 |
 >1 to ⩽3 cm | 22 (12.0) | 54 (29.5) | 32 (17.5) | 44 (24.0) | ||
 >3 to ⩽5 cm | 20 (10.9) | 22 (12.0) | 28 (15.3) | 14 (7.7) | ||
 >5 cm | 10 (5.5) | 7 (3.8) | 11 (6.0) | 6 (3.3) | ||
 N/Aa | 3 (1.6) | 9 (4.9) | 3 (1.6) | 9 (4.9) | ||
Multiplicity | ||||||
 Single | 28 (15.3) | 86 (47.0) | 0.37 | 60 (32.8) | 64 (35.0) | 0.16 |
 Multiple | 22 (12.0) | 37 (20.2) | 22 (12.0) | 37 (20.2) | ||
Stage (TNM staging system) | ||||||
 pTa | 9 (4.9) | 45 (24.6) | 0.01 | 13 (7.1) | 41 (22.4) | 0.001 |
 pT1 | 9 (4.9) | 30 (16.4) | 17 (9.3) | 22 (12.0) | ||
 pT2a | 16 (8.7) | 17 (9.3) | 23 (12.6) | 10 (5.5) | ||
 pT2b | 5 (2.7) | 7 (3.8) | 5 (2.7) | 7 (3.8) | ||
 pT3 | 7 (3.8) | 5 (2.7) | 8 (4.4) | 4 (2.2) | ||
 pN1/pN2 | 8 (4.4) | 11 (6.0) | 13 (7.1) | 6 (3.3) | ||
 M+ | 2 (1.1) | 2 (1.1) | 2 (1.1) | 2 (1.1) | ||
 N/Aa | 4 (2.2) | 6 (3.3) | 1 (0.5) | 9 (4.9) | ||
